Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.

MLA

Ferrari, Roberto, et al. “Current Practice in Identifying and Treating Cardiovascular Risk, with a Focus on Residual Risk Associated with Atherogenic Dyslipidaemia.” European Heart Journal Supplements : Journal of the European Society of Cardiology, vol. 18, no. Suppl C, Apr. 2016, pp. C2–12. EBSCOhost, https://doi.org/10.1093/eurheartj/suw009.

APA

Ferrari, R., Aguiar, C., Alegria, E., Bonadonna, R. C., Cosentino, F., Elisaf, M., Farnier, M., Ferrières, J., Filardi, P. P., Hancu, N., Kayikcioglu, M., Mello E Silva, A., Millan, J., Reiner, Ž., Tokgozoglu, L., Valensi, P., Viigimaa, M., Vrablik, M., Zambon, A., … Catapano, A. L. (2016). Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia. European Heart Journal Supplements : Journal of the European Society of Cardiology, 18(Suppl C), C2–C12. https://doi.org/10.1093/eurheartj/suw009

Chicago

Ferrari, Roberto, Carlos Aguiar, Eduardo Alegria, Riccardo C Bonadonna, Francesco Cosentino, Moses Elisaf, Michel Farnier, et al. 2016. “Current Practice in Identifying and Treating Cardiovascular Risk, with a Focus on Residual Risk Associated with Atherogenic Dyslipidaemia.” European Heart Journal Supplements : Journal of the European Society of Cardiology 18 (Suppl C): C2–12. doi:10.1093/eurheartj/suw009.